对肉毒毒素作为治疗雷诺氏病继发于硬质皮质症的治疗方法的系统审查
Calver Pang1,2, Despina Iakovou3,4, Danny Fraser3
1Department of Surgical Biotechnology, Division of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, London, UK. calverpang@doctors.org.uk.
Clinical rheumatology
|November 30, 2024
概括
玻尿酸毒素 (BTX) 显示出治疗雷诺现象 (RP) 二次性硬皮病的前景,显著改善疼痛和日常功能. 然而,目前的证据不足以确定BTX作为一线治疗,需要进一步研究.
科学领域:
- 类风湿病学 类风湿病学
- 神经学 神经学
- 皮肤病学 皮肤病学
背景情况:
- 雷诺现象 (RP) 是一种影响四肢的血管动性疾病,显著影响患者的生活质量.
- 毒素 (BTX) 已被探索作为RP的治疗方法,但其疗效仍然没有确定性.
研究的目的:
- 系统地审查目前关于BTX在治疗二次性硬化症的RP疗效的证据.
主要方法:
- 在主要的临床数据库 (Medline,Embase,Cochrane Library,ClinicalTrials.gov,欧盟临床试验注册表,ISRCTN) 进行了全面的搜索,直到2023年11月27日.
- 19项研究符合纳入标准,并使用随机效应模型进行分析,报告了快速DASH,VAS-P和RCS分数的标准平均差异.
主要成果:
- BTX治疗对快速DASH评分 (p=0.03) 和视觉模拟疼痛量表 (VAS-P) 评分 (p<0.00001) 产生显著影响.
- 对雷诺病状评分 (RCS) 的影响无意义 (p=0.37).
结论:
- 毒素 (BTX) 是一种潜在的治疗选择,用于RP二次性硬皮,显示在疼痛和功能评分的好处.
- 现有的证据不足以将BTX定位为一线革命性治疗;需要进一步研究以优化其使用.
更多相关视频
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
661
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
661
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Autonomic Nervous System
589
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
589


